Literature DB >> 27020440

New technology in electrophysiology: FDA process and perspective.

Kimberly A Selzman1, Mark Fellman2, Andrew Farb2, Sergio de Del Castillo2, Bram Zuckerman2.   

Abstract

The Food and Drug Administration (FDA) is a large regulatory agency that monitors everything from food, tobacco, and veterinary medicine to pharmaceutical drugs and medical devices. The Mission statement of the CDRH, one of the Centers of the FDA, in its most succinct form is to protect and promote public health. This is accomplished through timely and continued access to safe, effective, and high quality medical devices. This paper aims to review the overarching principles of the Agency's review process for cardiac devices as well as highlight some of the newer programs that FDA has engaged in to facilitate innovation, device development, research, and timely market approval.

Entities:  

Keywords:  Food and Drug Administration (FDA); Innovation; Post market surveillance; Regulatory science

Mesh:

Year:  2016        PMID: 27020440     DOI: 10.1007/s10840-016-0127-4

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  2 in total

Review 1.  Electrophysiology devices and the regulatory approval process within the U.S. FDA and abroad.

Authors:  Kimberly A Selzman; Hetal Patel; Kenneth Cavanaugh
Journal:  J Interv Card Electrophysiol       Date:  2019-08-16       Impact factor: 1.900

2.  Introduction: health policy II. A new era of heath policy in electrophysiology and cardiology.

Authors:  Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2016-09-16       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.